Home/Pipeline/Generic Portfolio Expansion - CNS

Generic Portfolio Expansion - CNS

Various CNS Disorders (e.g., pain, depression)

Regulatory SubmissionActiveN/A

Key Facts

Indication
Various CNS Disorders (e.g., pain, depression)
Phase
Regulatory Submission
Status
Active
Company

About Alkaloid AD Skopje

Alkaloid's mission is to improve health and quality of life by providing high-quality, accessible pharmaceutical and consumer healthcare products. The company has achieved a dominant market position in Southeast Europe, established a resilient export business, and built a reputation for reliability over nearly nine decades. Its strategy is centered on leveraging its integrated operations, portfolio diversification, and regional distribution strength to drive sustainable growth in both domestic and international generic drug and consumer health markets.

View full company profile